PREVIOUS
✖
Polyendocrine Metabolic Ovarian Syndrome
May 18 , 2026
15 hrs 0 min
9
0
- An international panel has renamed Polycystic Ovary Syndrome (PCOS) as Polyendocrine Metabolic Ovarian Syndrome (PMOS) to better reflect its biological complexity.
- The earlier term PCOS was considered misleading, as many patients do not have actual ovarian cysts, which are actually immature follicles.
- The new term PMOS highlights multiple hormone systems, including insulin, androgen, luteinising hormone (LH), and follicle-stimulating hormone (FSH).
- It also places metabolic dysfunction at the centre, linking the condition with insulin resistance, diabetes, obesity, fatty liver disease, and cardiovascular risks.
- Studies indicate that insulin resistance is present in nearly 70–80% of affected women, including those with normal body weight (“lean PMOS”).
Leave a Reply
Your Comment is awaiting moderation.